为评价血管紧张素转换酶抑制剂 (ACEI)在肾移植后高血压治疗中的作用。方法 :从肾移植后高血压的原因和机理及ACEI在肾移植后高血压中的应用等进行综合分析。结果 :ACEI能有效地控制血压 ;并对肾脏有保护作用 ,能明显地降低尿蛋白 ,改善肾脏血液动力学等 ;是治疗合并红细胞增多症和高血压的肾移植患者的首选药物 ;肾动脉狭窄是ACEI的禁忌症。结论 :ACEI是有选择治疗肾移植后高血压的有效药物。 To evaluate the role of angiotensin converting enzyme inhibitor (ACEI) in the treatment of hypertension after renal transplantation. Methods: The causes and mechanisms of hypertension after renal transplantation and the application of ACEI in hypertension after renal transplantation were analyzed. Results: ACEI can effectively control blood pressure, protect the kidneys, reduce the proteinuria and improve the hemodynamics of the kidneys. It is the first choice for the treatment of renal transplant patients with polycythemia and hypertension. Renal artery stenosis ACEI contraindications. Conclusion: ACEI is an effective drug for the treatment of hypertension after renal transplantation.